|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2331547 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09782051.8 |
| Date of filing the European patent application | 2009-08-20 | |
| (97) | Date of publication of the European application | 2011-06-15 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-30 |
| (46) | Date of publication of the claims translation | 2014-11-25 |
| (86) | Number | PCT/EP2009/060793 |
| Date | 2009-08-20 |
| (87) | Number | WO 2010/020675 |
| Date | 2010-02-25 |
| (30) | Number | Date | Country code |
| 91037 P | 2008-08-22 | US |
| (72) |
BESONG, Gilbert, GB
BRAIN, Christopher Thomas, US
BROOKS, Clinton A., US
CONGREVE, Miles Stuart, GB
DAGOSTIN, Claudio, GB
HE, Guo, US
HOU, Ying, US
HOWARD, Steven, GB
LI, Yue, CN
LU, Yipin, US
MORTENSON, Paul, GB
SMITH, Troy, US
SUNG, Moo, US
WOODHEAD, Steven, GB
WRONA, Wojciech, US
LAGU, Bharat, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Astex Therapeutics Ltd., 436 Cambridge Science Park Milton Road, Cambridge CB4 0QA, GB |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolopirimidino junginiai, kaip CDK inhibitoriai |
| PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 17 | 347.00 EUR |
| 2026-08-20 |